Skip to main navigation Skip to search Skip to main content

Immune responses in retinal gene therapy: challenges, mechanisms, and future strategies

  • Yawei Ma
  • , Yin Shen*
  • *Corresponding author for this work

Research output: Contribution to journal › Review › peer-review

11 Scopus citations

Abstract

Retinal gene therapy has advanced significantly, offering potential treatments for inherited retinal diseases (IRDs) such as retinitis pigmentosa, which previously lacked effective interventions. Central to this progress are adeno-associated virus (AAV)-based delivery systems, which have become the primary platform for ocular gene therapy due to their favorable safety profile, ability to target specific retinal cell types, and long-lasting therapeutic effects. However, accumulating evidence reveals that even "immune-privileged" retinal microenvironments are not exempt from immune challenges, affecting both the safety and efficacy of these therapies. Both innate immune pathways and adaptive responses can induce intraocular inflammation, leading to reduced transgene expression and compromised treatment. Understanding how these immune mechanisms interact with therapeutic outcomes is crucial for developing effective intervention strategies. This review examines evidence from both animal models and human trials to explore how immune activation affects treatment efficacy across various delivery methods and vector designs. We also assess emerging strategies aimed at protecting retinal function while reducing systemic toxicity.
Original languageEnglish
Article number1664968
Number of pages16
JournalFRONTIERS IN IMMUNOLOGY
Volume16
DOIs
StatePublished - 15 Oct 2025

Funding

The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by grants from the National Natural Science Foundation of China (NSFC No. 82471086), the Hubei Provincial Health and Health Technology Project (WJ2025Z003).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • retinal gene therapy
  • immune responses
  • inherited retinal diseases
  • adeno-associated virus (AAV)
  • immunomodulation

Indexed by

  • SCIE
  • Scopus

Fingerprint

Dive into the research topics of 'Immune responses in retinal gene therapy: challenges, mechanisms, and future strategies'. Together they form a unique fingerprint.

Cite this